FDA Adverse Event
Injury
Summary report: N
T:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY
MDR report key: 22816205
·
Received August 15, 2025
Report
- Report Number
- 3013756811-2025-193528
- Event Type
- Injury
- Date Received
- August 15, 2025
- Date of Event
- July 21, 2025
- Report Date
- August 15, 2025
- Manufacturer
- TANDEM DIABETES CARE
- Product Code
- QFG
- UDI-DI
- 00389152319513
- PMA / PMN Number
- K203234
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- WA, US
- Reporter Occupation
- OTHER
Narratives
Description of Event or Problem · 0
IT WAS REPORTED THAT THE CUSTOMER WENT TO THE EMERGENCY ROOM ON (B)(6) 2025 AND WAS LATER ADMITTED TO THE INTENSIVE CARE UNIT WITH AN ELEVATED BLOOD GLUCOSE LEVEL OF 900-994 MG/DL. ELEVATED BLOOD GLUCOSE LEVEL CAUSED CUSTOMER TO HAVE MULTIPLE SEIZURES, LOSE CONSCIOUSNESS, AND HAVE A HEART ATTACK. CUSTOMER WAS TREATED WITH INTRAVENOUS FLUIDS OF SALINE AND INSULIN. CUSTOMER WAS DISCHARGED ON (B)(6) 2025 WITH THE ISSUE RESOLVED AND NO PERMANENT DAMAGE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1239850 | T:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY | ALTERNATE CONTROLLER ENABLED INSULIN INFUSION PUMP | QFG | TANDEM DIABETES CARE | 1002717 | 00389152319513 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 55 YR | Female | Required Intervention| L| H | NOVOLOG / NOVORAPID - INSULIN. |